05:36 AM EDT, 05/28/2024 (MT Newswires) -- Evotec SE ( EVO ) said Tuesday it extended its strategic drug discovery collaboration with CHDI Foundation for Huntington's disease.

The collaboration, which started in 2006, leverages the company's integrated neuroscience platform and capabilities in drug discovery and development to develop new therapies for Huntington's disease, the company said.

Price: 4.7500, Change: -0.02, Percent Change: -0.42